EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS21 - ENT 1

Friday 31 May, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
A first structured diagnostic approach to identify underlying diseases of patients with acquired angioedema
Anti-allergic effect of lidocaine-derived organic compounds in an Allergic rhinitis mouse model
Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Polyangiitis (EGPA) patients at time of diagnosis: our experience
Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps
Investigating the Role of Skin Prick and Specific IgE Tests in Nasal Provocation Test Outcomes for Allergic Rhinitis Diagnosis
Involvement of activation of mast cells via IgE signaling and epithelial cell-derived cytokines in the pathogenesis of pollen-food allergy syndrome in a novel murine model
Minimal Invasive Endotyping in Nasal Inflammatory Disease
Ocular symptoms in Local Allergic Rhinitis
Performance of 5 item and 22 item sino-nasal outcome tests in response to dupilumab in chronic rhinosinusitis with nasal polyps
Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
Regional rates of sensitization and otolaryngic pathology in children with approved allergic rhinitis in Russian Federation
Serious secondary effect of rhinitis self-treatment: Reversible Cerebral Vasoconstriction Syndrome (RCVS)
TLR4+ILC2 cells contribute to persistent type 2 immunity in airway diseases
The correlation between chronic rhinosinusitis with/without nasal polyp and chronic kidney disease: a longitudinal follow-up study
The survey of perennial allergic rhinitis caused by house dust mites among the elementary school students in Fukui, Japan
Use of Corticosteroids and History of Surgery Among Patients with CRSwNP Initiating Dupilumab in the Global AROMA registry

Speakers